Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Contemporary Topics in Critical Care With Evolving Medication Management Considerations.

Kane-Gill SL, Dzierba AL.

J Pharm Pract. 2019 Jun;32(3):254-255. doi: 10.1177/0897190019857822. No abstract available.

PMID:
31291841
2.

Sufentanil Sublingual Tablet: A New Option for Acute Pain Management.

Reardon CE, Kane-Gill SL, Smithburger PL, Dasta JF.

Ann Pharmacother. 2019 Jul 7:1060028019863144. doi: 10.1177/1060028019863144. [Epub ahead of print]

PMID:
31280585
3.

Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.

Kane-Gill SL, Ostermann M, Shi J, Joyce EL, Kellum JA.

Drug Saf. 2019 Jun 25. doi: 10.1007/s40264-019-00846-x. [Epub ahead of print]

PMID:
31240688
4.

Quality Improvement Goals for Acute Kidney Injury.

Kashani K, Rosner MH, Haase M, Lewington AJP, O'Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):941-953. doi: 10.2215/CJN.01250119. Epub 2019 May 17.

PMID:
31101671
5.

Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Fitzmaurice MG, Wong A, Akerberg H, Avramovska S, Smithburger PL, Buckley MS, Kane-Gill SL.

Drug Saf. 2019 Sep;42(9):1035-1044. doi: 10.1007/s40264-019-00829-y. Review.

PMID:
31098917
6.

Expansion of Telemedicine Services: Telepharmacy, Telestroke, Teledialysis, Tele-Emergency Medicine.

Kane-Gill SL, Rincon F.

Crit Care Clin. 2019 Jul;35(3):519-533. doi: 10.1016/j.ccc.2019.02.007. Epub 2019 Apr 7. Review.

PMID:
31076051
7.

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review.

Barreto EF, Rule AD, Murad MH, Kashani KB, Lieske JC, Erwin PJ, Steckelberg JM, Gajic O, Reid JM, Kane-Gill SL.

Mayo Clin Proc. 2019 Mar;94(3):500-514. doi: 10.1016/j.mayocp.2018.08.002. Epub 2019 Jan 31. Review.

PMID:
30713050
8.

Evaluating intensive care unit medication charges in a teaching hospital in Jordan.

Altawalbeh SM, Abu-Su'Ud R, Alefan Q, Momany SM, Kane-Gill SL.

Expert Rev Pharmacoecon Outcomes Res. 2019 Jan 28:1-7. doi: 10.1080/14737167.2019.1571413. [Epub ahead of print]

PMID:
30663452
9.

Evaluation of pharmacist satisfaction with simulation-based learning in Singapore.

Ong CL, Kane-Gill SL, Kobulinsky LR, Hon JS, Kong MC, Seybert AL.

Curr Pharm Teach Learn. 2018 Oct;10(10):1414-1418. doi: 10.1016/j.cptl.2018.07.004. Epub 2018 Aug 8.

PMID:
30527371
10.

Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.

Buckley MS, Barletta JF, Smithburger PL, Radosevich JJ, Kane-Gill SL.

Pharmacotherapy. 2019 Mar;39(3):382-398. doi: 10.1002/phar.2199. Epub 2019 Jan 2. Review.

PMID:
30506565
11.

Assessing Adverse Drug Reactions from Psychotropic Medications Reported to the U.S. Food and Drug Administration in Older Adults.

Gray MP, Dziuba G, Quach K, Wong A, Smithburger PL, Seybert AL, Kane-Gill SL.

Am J Geriatr Psychiatry. 2019 Feb;27(2):181-185. doi: 10.1016/j.jagp.2018.09.013. Epub 2018 Sep 27.

PMID:
30503701
12.

Pharmacologic Management of Delirium in the ICU: A Review of the Literature.

Korenoski A, Li A, Kane-Gill SL, Seybert AL, Smithburger PL.

J Intensive Care Med. 2018 Oct 11:885066618805965. doi: 10.1177/0885066618805965. [Epub ahead of print]

PMID:
30309280
13.

Predictors of resistant alcohol withdrawal (RAW): A retrospective case-control study.

Benedict NJ, Wong A, Cassidy E, Lohr BR, Pizon AF, Smithburger PL, Falcione BA, Kirisci L, Kane-Gill SL.

Drug Alcohol Depend. 2018 Nov 1;192:303-308. doi: 10.1016/j.drugalcdep.2018.08.017. Epub 2018 Oct 2.

PMID:
30308384
14.

Innovations in Medication Safety: Services and Technologies to Enhance the Understanding and Prevention of Adverse Drug Reactions.

Kane-Gill SL.

Pharmacotherapy. 2018 Aug;38(8):782-784. doi: 10.1002/phar.2154. Epub 2018 Jul 22. No abstract available.

PMID:
30033608
15.

A Systematic Review of ICU and Non-ICU Clinical Pharmacy Services Using Telepharmacy.

Strnad K, Shoulders BR, Smithburger PL, Kane-Gill SL.

Ann Pharmacother. 2018 Dec;52(12):1250-1258. doi: 10.1177/1060028018787213. Epub 2018 Jul 9.

PMID:
29984590
16.

β-Lactams: The Competing Priorities of Nephrotoxicity, Neurotoxicity, and Stewardship.

Barreto EF, Mueller BA, Kane-Gill SL, Rule AD, Steckelberg JM.

Ann Pharmacother. 2018 Nov;52(11):1167-1168. doi: 10.1177/1060028018783984. Epub 2018 Jun 20. No abstract available.

PMID:
29923415
17.

Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications.

Barreto EF, Rule AD, Voils SA, Kane-Gill SL.

Pharmacotherapy. 2018 Aug;38(8):794-803. doi: 10.1002/phar.2149. Epub 2018 Jul 13. Review.

PMID:
29883532
18.

Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.

Welch HK, Kellum JA, Kane-Gill SL.

Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.

PMID:
29883524
19.

Adjunct Ketamine Use in the Management of Severe Ethanol Withdrawal.

Pizon AF, Lynch MJ, Benedict NJ, Yanta JH, Frisch A, Menke NB, Swartzentruber GS, King AM, Abesamis MG, Kane-Gill SL.

Crit Care Med. 2018 Aug;46(8):e768-e771. doi: 10.1097/CCM.0000000000003204.

PMID:
29742583
20.

Trigger alerts associated with laboratory abnormalities on identifying potentially preventable adverse drug events in the intensive care unit and general ward.

Buckley MS, Rasmussen JR, Bikin DS, Richards EC, Berry AJ, Culver MA, Rivosecchi RM, Kane-Gill SL.

Ther Adv Drug Saf. 2018 Apr;9(4):207-217. doi: 10.1177/2042098618760995. Epub 2018 Mar 1.

21.

A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections.

Turco NJ, Kane-Gill SL, Hernandez I, Oleksiuk LM, D'Amico F, Pickering AJ.

Expert Opin Pharmacother. 2018 Mar;19(4):319-325. doi: 10.1080/14656566.2018.1442439. Epub 2018 Mar 6.

PMID:
29509504
22.

Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review.

Hammond DA, Rowe JM, Wong A, Wiley TL, Lee KC, Kane-Gill SL.

Hosp Pharm. 2017 Oct;52(9):607-616. doi: 10.1177/0018578717720310. Epub 2017 Jul 17.

23.

AKD-The Time Between AKI and CKD: What Is the Role of the Pharmacist?

Kane-Gill SL, Bauer SR.

Hosp Pharm. 2017 Nov;52(10):663-665. doi: 10.1177/0018578717733561. Epub 2017 Sep 27. No abstract available.

24.

Automated Screening of Emergency Department Notes for Drug-Associated Bleeding Adverse Events Occurring in Older Adults.

Boyce RD, Jao J, Miller T, Kane-Gill SL.

Appl Clin Inform. 2017 Oct;8(4):1022-1030. doi: 10.4338/ACI-2017-02-RA-0036. Epub 2017 Dec 14.

25.

Perceptions of Families of Intensive Care Unit Patients Regarding Involvement in Delirium-Prevention Activities: A Qualitative Study.

Smithburger PL, Korenoski AS, Alexander SA, Kane-Gill SL.

Crit Care Nurse. 2017 Dec;37(6):e1-e9. doi: 10.4037/ccn2017485.

26.

Perceptions of Family Members, Nurses, and Physicians on Involving Patients' Families in Delirium Prevention.

Smithburger PL, Korenoski AS, Kane-Gill SL, Alexander SA.

Crit Care Nurse. 2017 Dec;37(6):48-57. doi: 10.4037/ccn2017901.

27.

Technological Distractions (Part 2): A Summary of Approaches to Manage Clinical Alarms With Intent to Reduce Alarm Fatigue.

Winters BD, Cvach MM, Bonafide CP, Hu X, Konkani A, O'Connor MF, Rothschild JM, Selby NM, Pelter MM, McLean B, Kane-Gill SL; Society for Critical Care Medicine Alarm and Alert Fatigue Task Force.

Crit Care Med. 2018 Jan;46(1):130-137. doi: 10.1097/CCM.0000000000002803. Review.

PMID:
29112077
28.

Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review.

Niznik JD, He H, Kane-Gill SL.

Res Social Adm Pharm. 2018 Aug;14(8):707-717. doi: 10.1016/j.sapharm.2017.10.011. Epub 2017 Oct 28. Review.

PMID:
29100941
29.

Intensive care unit drug costs in the context of total hospital drug expenditures with suggestions for targeted cost containment efforts.

Altawalbeh SM, Saul MI, Seybert AL, Thorpe JM, Kane-Gill SL.

J Crit Care. 2018 Apr;44:77-81. doi: 10.1016/j.jcrc.2017.10.029. Epub 2017 Oct 19.

PMID:
29073536
30.

Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.

Ostermann M, Chawla LS, Forni LG, Kane-Gill SL, Kellum JA, Koyner J, Murray PT, Ronco C, Goldstein SL; ADQI 16 workgroup.

Br J Clin Pharmacol. 2018 Feb;84(2):396-403. doi: 10.1111/bcp.13449. Epub 2017 Dec 1.

31.

Clinical Practice Guideline: Safe Medication Use in the ICU.

Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, George EL, Pohlman AS, Agarwal S, Henneman EA, Bejian SM, Berenholtz SM, Pepin JL, Scanlon MC, Smith BS.

Crit Care Med. 2017 Sep;45(9):e877-e915. doi: 10.1097/CCM.0000000000002533.

PMID:
28816851
32.

Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU.

Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, George EL, Pohlman AS, Agarwal S, Henneman EA, Bejian SM, Berenholtz SM, Pepin JL, Scanlon MC, Smith BS.

Crit Care Med. 2017 Sep;45(9):1546-1551. doi: 10.1097/CCM.0000000000002519. No abstract available.

PMID:
28816838
33.

Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences.

Hammond DA, Oyler DR, Devlin JW, Painter JT, Bolesta S, Swanson JM, Bailey BJ, Branan T, Barletta JF, Dunn B, Haney JS, Juang P, Kane-Gill SL, Kiser TH, Shafeeq H, Skaar D, Smithburger P, Taylor J.

Am J Pharm Educ. 2017 Jun;81(5):90. doi: 10.5688/ajpe81590.

34.

Technologic Distractions (Part 1): Summary of Approaches to Manage Alert Quantity With Intent to Reduce Alert Fatigue and Suggestions for Alert Fatigue Metrics.

Kane-Gill SL, O'Connor MF, Rothschild JM, Selby NM, McLean B, Bonafide CP, Cvach MM, Hu X, Konkani A, Pelter MM, Winters BD.

Crit Care Med. 2017 Sep;45(9):1481-1488. doi: 10.1097/CCM.0000000000002580. Review.

PMID:
28682835
35.

Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.

Kane-Gill SL, Smithburger PL, Kashani K, Kellum JA, Frazee E.

Drug Saf. 2017 Nov;40(11):1049-1074. doi: 10.1007/s40264-017-0565-7. Review.

PMID:
28674842
36.

The Impact of Mortality on Total Costs Within the ICU.

Kramer AA, Dasta JF, Kane-Gill SL.

Crit Care Med. 2017 Sep;45(9):1457-1463. doi: 10.1097/CCM.0000000000002563.

PMID:
28658024
37.

Characterization of Guideline Evidence for Off-label Medication Use in the Intensive Care Unit.

Shoulders BR, Smithburger PL, Tchen S, Buckley M, Lat I, Kane-Gill SL.

Ann Pharmacother. 2017 Jul;51(7):529-542. doi: 10.1177/1060028017699635. Epub 2017 Mar 15.

PMID:
28622741
38.

A retrospective analysis of the effectiveness of antipsychotics in the treatment of ICU delirium.

Weaver CB, Kane-Gill SL, Gunn SR, Kirisci L, Smithburger PL.

J Crit Care. 2017 Oct;41:234-239. doi: 10.1016/j.jcrc.2017.05.034. Epub 2017 Jun 1.

PMID:
28595082
39.

Use of Telemedicine to Enhance Pharmacist Services in the Nursing Facility.

Kane-Gill SL, Niznik JD, Kellum JA, Culley CM, Boyce RD, Marcum ZA, He H, Perera S, Handler SM.

Consult Pharm. 2017 Feb 1;32(2):93-98. doi: 10.4140/TCP.n.2017.93. Review.

40.

Adverse drug reactions in therapeutic hypothermia after cardiac arrest.

Witcher R, Dzierba AL, Kim C, Smithburger PL, Kane-Gill SL.

Ther Adv Drug Saf. 2017 Mar;8(3):101-111. doi: 10.1177/2042098616679813. Epub 2016 Nov 29.

41.

Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel.

Verlinden NJ, Coons JC, Iasella CJ, Kane-Gill SL.

J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):546-551. doi: 10.1177/1074248417698042. Epub 2017 Mar 9.

PMID:
28279076
42.

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.

Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA; Acute Disease Quality Initiative Workgroup 16.

Nat Rev Nephrol. 2017 Apr;13(4):241-257. doi: 10.1038/nrneph.2017.2. Epub 2017 Feb 27.

PMID:
28239173
43.

The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy.

Rivosecchi RM, Kane-Gill SL, Garavaglia J, MacLasco A, Johnson H.

Int J Pharm Pract. 2017 Dec;25(6):463-465. doi: 10.1111/ijpp.12355. Epub 2017 Feb 17.

PMID:
28211589
44.

Physician Perceptions of Consultant Pharmacist Services Associated with an Intervention for Adverse Drug Events in the Nursing Facility.

Kane-Gill SL, Hanlon JT, Fine MJ, Perera S, Culley CM, Studenski SA, Nace DA, Boyce RD, Castle NG, Handler SM.

Consult Pharm. 2016 Dec 1;31(12):708-720. doi: 10.4140/TCP.n.2016.708.

45.

Clinical decision support for drug related events: Moving towards better prevention.

Kane-Gill SL, Achanta A, Kellum JA, Handler SM.

World J Crit Care Med. 2016 Nov 4;5(4):204-211. eCollection 2016 Nov 4. Review.

46.

The Importance of Research and Scholarly Activity in Pharmacy Training.

Deal EN, Stranges PM, Maxwell WD, Bacci J, Ashjian EJ, DeRemer DL, Kane-Gill SL, Norgard NB, Dombrowski L, Parker RB; American College of Clinical Pharmacy.

Pharmacotherapy. 2016 Dec;36(12):e200-e205. doi: 10.1002/phar.1864. Epub 2016 Nov 25.

PMID:
27885711
47.

Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.

Groetzinger LM, Rivosecchi RM, Kane-Gill SL, Donahoe MP.

Ann Pharmacother. 2016 Dec;50(12):1009-1015. Epub 2016 Aug 10.

PMID:
27511813
48.

Outcome Assessment of Critical Care Pharmacist Services.

Bauer SR, Kane-Gill SL.

Hosp Pharm. 2016 Jul;51(7):507-13. doi: 10.1310/hpj5107-507. No abstract available.

49.

Use of Text Searching for Trigger Words in Medical Records to Identify Adverse Drug Reactions within an Intensive Care Unit Discharge Summary.

Kane-Gill SL, MacLasco AM, Saul MI, Politz Smith TR, Kloet MA, Kim C, Anthes AM, Smithburger PL, Seybert AL.

Appl Clin Inform. 2016 Jul 13;7(3):660-71. doi: 10.4338/ACI-2016-03-RA-0031.

50.

Drug Class Combination-Associated Acute Kidney Injury.

Rivosecchi RM, Kellum JA, Dasta JF, Armahizer MJ, Bolesta S, Buckley MS, Dzierba AL, Frazee EN, Johnson HJ, Kim C, Murugan R, Smithburger PL, Wong A, Kane Gill SL.

Ann Pharmacother. 2016 Nov;50(11):953-972. doi: 10.1177/1060028016657839. Epub 2016 Oct 1. Review.

PMID:
27389325

Supplemental Content

Loading ...
Support Center